Skip to content

Interest coverage at other companies

Avanos Medical logo
Avanos MedicalAVNS
-9.1×-3.9×
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
2.4×+0.6×
AtriCure logo
AtriCureATRC
-4.5×-0.4×

Other financials

Income statement

See full
Revenue$177.4M+5.0%
Gross profit$141.0M+4.7%
Operating income$6.9M+247%
Net income$2.9M-39.4%
EPS (diluted)$0.07-30.0%

Balance sheet

See full
Cash & equivalents$144.3M-49.1%
Total debt$411.2M+15.3%
Total equity$653.9M-18.1%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow$25.7M-27.6%
CapEx$2.7M-68.1%
Free cash flow$23.0M-14.7%

Valuation

See full
Market cap$942.78M-16.0%
Enterprise value$1.21B+1.2%
P/E183.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin79.3%+1.7pp
Operating margin3.3%
Net margin0.7%
FCF margin18.1%-4.6pp

Returns & leverage

See full
Return on equity0.7%
Debt / equity0.6×+0.2×
Current ratio4.7×+2.3×

Where this comes from

Calculated from Pacira BioSciences, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s interest coverage?
Pacira BioSciences, Inc. (PCRX) reported interest coverage of 1.5× in Q1 2026.
What is the long-term trend for Pacira BioSciences, Inc.'s interest coverage?
Over 3 years (2020 to 2025), Pacira BioSciences, Inc.'s interest coverage has grown at a -15.2% compound annual growth rate (CAGR), from 1.8× to 1.1×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.